A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2
Waisbourd-Zinman, Orith¹; Surrey, Lea F¹; Schwartz, Anna E¹; Russo, Pierre A¹; Wen, Jessica^1
1Children's Hospital of Philadelphia, Division of Gastroenterology, Hepatology and Nutrition, Filadelfia, Pensilvania. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 465-468]

Cholangiohydatidosis: An infrequent cause of obstructive jaundice and acute cholangitis
Manterola, Carlos¹; Otzen, Tamara^2
1Universidad de La Frontera, Centro de Estudios Morfológicos y Quirúrgicos, Temuco, Cautín. Chile; ²Universidad Autónoma de Chile, Centro de Investigación Biomédica, Temuco, Cautín. Chile
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 436-441]

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B
Oyagüez, Itziar¹; Buti, María²; Brosa, Max³; Rueda, Magdalena⁴; Casado, Miguel A^1
1Pharmacoeconomics & Outcomes Research Iberia, Pozuelo de Alarcón, Madrid. España; ²Hospital de la Vall d'Hebron, Barcelona. España; ³Oblikue Consulting, Barcelona. España; ⁴Gilead Sciences, Madrid. España
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 358-365]

Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy
Langness, Jacob A¹; Tabano, David²; Wieland, Amanda³; Tise, Sarah³; Pratt, Lindsay³; Ayres Harrington, Lauren¹; Lin, Sonia¹; Ghuschcyan, Vahram²; Nair, Kavita V²; Everson, Gregory T^3
1University Of Colorado Hospital, Department of Pharmacy, Aurora, Colorado. Estados Unidos de América; ²University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado. Estados Unidos de América; ³University of Colorado Denver, School of Medicine, Denver, Colorado. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 366-374]

Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality
Rathi, Chetan¹; Pipaliya, Nirav¹; Patel, Ruchir¹; Ingle, Meghraj¹; Phadke, Aniruddha¹; Sawant, Prabha^1
1Lokmanya Tilak Municipal Medical College, Department of Gastroenterology, Bombay, Maharashtra. India
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 442-450]

GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors
Greni, Federico¹; Valenti, Luca²; Mariani, Raffaella³; Pelloni, Irene³; Rametta, Raffaela²; Busti, Fabiana⁴; Piperno, Alberto¹; Ravasi, Giulia¹; Girelli, Domenico⁴; Fargion, Silvia²; Galimberti, Stefania¹; Pelucchi, Sara^1
1Universita di Milano-Bicocca, Scuola di Medicina e Chirurgia, Monza, Lombardía. Italia; ²Universita di Milano, Ospedale Maggiore Policlinico, Milán, Lombardia. Italia; ³Azienda Socio Sanitaria Territoriale di Monza, Ospedale San Gerardo, Monza, Lombardía. Italia; ⁴Universita di Verona, Policlinico GB Rossi, Verona, Veneto. Italia
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 451-456]

HbA1c Levels as a Parameter of Glycemic Control in Patients with Liver Diseases
Schiavon, Leonardo de Lucca¹; Narciso-Schiavon, Janaina Luz^1
1Universidade Federal de Santa Catarina, Hospital Universitario, Florianopolis, Santa Catarina. Brasil
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 469-470]

Liver Transplantation as Cure of Hepatocellular Carcinoma: It is not a Matter of Time, it is a Matter of Tumor Biology
Jochum, Christoph¹; Canbay, Ali^2
1University Duisburg-Essen, University Hospital, Essen, Nordrhein-Westfalen. Alemania; ²Otto von Guericke University, Department of Gastroenterology, Hepatology and Infectious Diseases, Magdeburgo, Sajonia-Anhalt. Alemania
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 326-327]

Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center
Palmer, William C¹; Lee, David¹; Burns, Justin¹; Croome, Kristopher¹; Rosser, Barry¹; Patel, Tushar¹; Keaveny, Andrew P¹; Pungpapong, Surakit¹; Satyanarayana, Raj; Yataco, Maria¹; Nakhleh, Raouf²; Musto, Kaitlyn R¹; Canabal, Alexandra M³; Turnage, Alex K³; Hodge, David O⁴; Nguyen, Justin H¹; Harnois, Denise M^1
1Mayo Clinic, Department of Transplant, Jacksonville, Florida. Estados Unidos de América; ²Mayo Clinic, Department of Pathology, Jacksonville, Florida. Estados Unidos de América; ³Mayo Clinic, CRISP Program, Jacksonville, Florida. Estados Unidos de América; ⁴Mayo Clinic, Department of Health Sciences Research, Jacksonville, Florida. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 402-411]

MRE in NAFLD: Promising but Further Validation is Required
Ryan, John D¹; Tsochatzis, Emmanuel A^1
1Royal Free Hospital, Sheila Sherlock Liver Unit, Londres. Reino Unido
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 331-332]

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant
Yoshida, Eric M¹; Kwo, Paul²; Agarwal, Kosh³; Duvoux, Christophe⁴; Durand, Francois⁵; Peck Radosavljevic, Markus⁶; Lilly, Leslie⁷; Willems, Bernard⁸; Vargas, Hugo⁹; Kumar, Princy¹⁰; Brown-Junior, Robert S¹¹; Horsmans, Yves¹²; De Oertel, Shampa¹³; Arterburn, Sarah¹³; Dvory Sobol, Hadas¹³; Brainard, Diana M¹³; McHutchison, John G¹³; Terrault, Norah¹⁴; Rizzetto, Mario¹⁵; Mullhaupt, Beat^16
1Vancouver General Hospital, Division of Gastroenterology, Vancouver, Columbia Británica. Canadá; ²Indiana University, School of Medicine, Indianapolis, Indiana. Estados Unidos de América; ³King’s College Hospital Foundation Trust, Institute of Liver Studies, Londres. Reino Unido; ⁴Universite Paris-Est Creteil, Centre Hospitalier Universitaire Henri-Mondor, Val de Marne, París. Francia; ⁵Universite Paris Diderot, Beaujon Hospital, Clichy, París. Francia; ⁶Medical University of Vienna, Department of Gastroenterology and Hepatology, Viena. Austria; ⁷University of Toronto, Toronto General Hospital, Toronto, Ontario. Canadá; ⁸Universite de Montreal, Hospital Saint Luc, Montreal, Quebec. Canadá; ⁹Mayo Clinic, Division of Gastroenterology and Hepatology, Phoenix, Arizona. Estados Unidos de América; ¹⁰Georgetown University, Division of Infectious Diseases, Washington, Distrito de Columbia. Estados Unidos de América; ¹¹Weill Cornell Medical College, Division of Gastroenterology and Hepatology, Nueva York. Estados Unidos de América; ¹²Universite Catholique de Louvain, Lovaina. Bélgica; ¹³Gilead Sciences, Inc., Foster City, California. Estados Unidos de América; ¹⁴University of California, Division of Gastroenterology and Hepatology, San Francisco, California. Estados Unidos de América; ¹⁵Universita di Torino, Dipartimento di Gastroenterologia, Turín, Piemonte. Italia; ¹⁶University Hospital Zurich, Department for Gastroenterology and Hepatology, Zurich. Suiza
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 375-381]

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
Vinaixa, Carmen¹; Berenguer, Marina^1
1Hospital Universitari i Politecnic La Fe, Departamento de Gastroenterología, Valencia. España
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 322-323]

Prospective Indian Study of DILI with Confirmed Causality Using the Roussel Uclaf Causality Assessment Method (RUCAM): A Report of Excellence
Teschke, Rolf¹; Danan, Gaby
¹Goethe University, Medical Faculty, Frankfurt, Hessen. Alemania
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 324-325]

Recurrent Hyperammonemia After Abernethy Malformation Type 2 Closure: a Case Report
Li, Hui¹; Ma, Zhi¹; Xie, Ying¹; Tian, Feng^1
1China Medical University, Shengjing Hospital, Shenyang, Liaoning. China
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 460-464]

Reply to “HbA1c Levels as a Parameter of Glycemic Control in Patients with Liver Cirrhosis”
Stine, Jonathan G¹; Wynter, Javelle A¹; Niccum, Blake¹; Kelly, Virginia¹; Caldwell, Stephen H¹; Shah, Neeral L¹; Narciso-Schiavon, Janaina Luz^1
1University of Virginia, School of Medicine, Charlottesville, Virginia. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 471-472]

Risk Factors for Prognosis of Hepatocellular Carcinoma After Curative Resection In Patients with Low Hepatitis B Viral Load
Qu, Li-Shuai¹; Liu, Jin-Xia¹; Zhu, Jing¹; Lu, Cui-Hua^1
1Affiliated Hospital of Nantong University, Department of Gastroenterology, Nantong. China
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 412-420]

Spontaneous Resolution of Multiple Hepatic Masses: Hepatic Inflammatory Pseuduotumor
Qi, Xingshun¹; Han, Lei²; Arora, Ankur³; Hou, Yue¹; Wang, Ran¹; Chang, Sha¹; Guo, Xiaozhong^1
1General Hospital of Shenyang, Department of Gastroenterology, Shenyang, Liaoning. China; ²General Hospital of Shenyang, Department of Hepatobiliary Surgery, Shenyang, Liaoning. China; ³Worthing Hospital, Department of Radiology, Worthing, West Sussex. Reino Unido
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 457-459]

Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis
Chaiteerakij, Roongruedee¹; Chattieng, Piyanat¹; Choi, Jonggi²; Pinchareon, Nutcha¹; Thanapirom, Kessirin¹; Geratikornsupuk, Nopavut^1
1Thai Red Cross Society, King Chulalongkorn Memorial Hospital, Bangkok, Phra Nakhon. Tailandia; ²Presence Saint Francis Hospital, Department of Internal Medicine, Evanston, Illinois. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 421-429]

Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Jaruvongvanich, Veeravich¹; Sanguankeo, Anawin²; Riangwiwat, Tanawan¹; Upala, Sikarin^2
1University of Hawaii, Department of Internal Medicine, Honolulu, Hawaii. Estados Unidos de América; ²Bassett Medical Center, Department of Internal Medicine, Cooperstown, New York. Estados Unidos de América
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 382-394]

The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
Chinchilla López, Paulina¹; Qi, Xingshun²; Yoshida, Eric M³; Méndez Sánchez, Nahum^1
1Fundación Clínica Médica Sur, Unidad de Investigación de Hígado, Ciudad de México. México; ²General Hospital of Shenyang Military Area, Department of Gastroenterology, Shenyang, Liaoning. China; ³Vancouver General Hospital, Division of Gastroenterology, Vancouver, Columbia Británica. Canadá
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 328-330]